Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nexalin Technology (NXL) EBIT (2021 - 2025)

Nexalin Technology has reported EBIT over the past 5 years, most recently at $4.3 million for Q4 2025.

  • Quarterly results put EBIT at $4.3 million for Q4 2025, up 247.87% from a year ago — trailing twelve months through Dec 2025 was -$1.7 million (up 77.74% YoY), and the annual figure for FY2025 was -$1.7 million, up 77.74%.
  • EBIT for Q4 2025 was $4.3 million at Nexalin Technology, up from -$2.3 million in the prior quarter.
  • Over the last five years, EBIT for NXL hit a ceiling of $4.3 million in Q4 2025 and a floor of -$2.9 million in Q4 2024.
  • Median EBIT over the past 5 years was -$1.2 million (2024), compared with a mean of -$1.1 million.
  • Biggest five-year swings in EBIT: crashed 723.87% in 2023 and later soared 247.87% in 2025.
  • Nexalin Technology's EBIT stood at -$577489.0 in 2021, then fell by 24.61% to -$719617.0 in 2022, then crashed by 125.74% to -$1.6 million in 2023, then tumbled by 77.0% to -$2.9 million in 2024, then soared by 247.87% to $4.3 million in 2025.
  • The last three reported values for EBIT were $4.3 million (Q4 2025), -$2.3 million (Q3 2025), and -$1.6 million (Q2 2025) per Business Quant data.